With a unique legacy in dermatology as well as decades of cutting-edge innovation, Galderma is the leading company solely dedicated to skin and advancing the future of dermatology.
We deliver an innovative, science-based portfolio of sophisticated brands and services across Aesthetics, Consumer Care and Prescription Medicine.
Through trusted partnerships with healthcare professionals, we ensure to meet individual consumer and patient needs with superior outcomes.
KEY FACTS ABOUT GALDERMA
audited 2020 net sales
employees in 100 countries
employees work at our 4 manufacturing sites. We make 75% of our products in house.
Global Business Units: Aesthetics, Consumer Care and Prescription Medicine
we operate from 50 sites in 40 countries, with our headquarters in Switzerland.
A timeline of our history
Foundation of Galderma as a joint venture between L’Oréal and Nestlé
Following the invention of the first Cetaphil formulation in 1947
Galderma discovers Adapalene
First commercial operations
Launch of Differin for acne treatment
Opening of our production site in Baie d’Urfé, Canada
Licensing agreement for Metvix (Skin cancer)
Opening of our production site in Hortolândia, Brazil
Launch of Differin 0.3%
Launch of Epiduo
Launch of Azzalure and Restylane Injector